🔗 Share this article

Grammy-winning R&B singer D’Angelo died on October 14 at 51 years old after a private battle with pancreatic malignancy.

“The brilliant light of our family has faded away for us in the present world,” his relatives stated. “After a prolonged and courageous struggle with the disease, we are deeply saddened to declare that Michael D’Angelo Archer, recognized by his fans around the world as D’Angelo, has been called home.”

D’Angelo made a lasting impact on the music industry with his innovative neo-soul sound and collaborations with renowned musicians.

He launched his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The record achieved the fourth spot on the R&B charts, earned platinum status later that year, and received multiple Grammy nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his music career into the limelight. The album premiered at the top spot on each of the R&B charts and the main album chart. He received two Grammy Awards: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a hesitant one, in the public consciousness. The intimate portrayal showed the artist, notably bare to his midsection, singing straight into the camera.

D’Angelo retreated from the spotlight after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a serious car crash that left him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his lasting popularity with a further top chart entry on the R&B chart and a Grammy for Top R&B Record.

Again, in his own enigmatic fashion, D’Angelo made only a few public outings in the subsequent period.

The singer was announced as a top act for the 2025 music event, but his performance was canceled, due to an “unexpected health issue.”

Although details are sparse about D’Angelo’s well-being in the months leading up to his passing, he had reportedly been hospitalized for months and in palliative care for a fortnight.

D’Angelo’s passing is a clear example of the devastating effects of pancreatic cancer, one of the most deadly and least preventable types of the illness, on a brilliant talent whose existence was ended too soon.

“We are saddened that he can only provide dear memories with his loved ones, but we are eternally grateful for the legacy of deeply emotional music he has left us,” his family expressed.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic cancer impacts the digestive organ, a small organ that produces insulin and is vital in digestion, among additional roles. The size and location of the organ in the human system make it more challenging to identify malignancy.

Even though this cancer accounts for only about 3% of cancer diagnoses each year in the U.S., it is causes 7% of cancer deaths.

Almost seventy thousand individuals will be diagnosed with pancreatic cancer and roughly fifty-two thousand will die of the disease in 2025.

“This malignancy is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have few and poor treatment options, and a smaller window to make a significant difference on the lives of patients,” said a cancer specialist.

Because pancreatic cancer rarely causes early symptoms, it’s frequently diagnosed only after the condition is late-stage. Although a patient has indicators they are often vague and may be confused with a number of everyday ailments.

“Currently, there is no good way to identify pancreatic cancer in the initial phases, except for paying attention to physical changes and consulting your doctor if there are unfamiliar symptoms,” said a medical director.

Frequent indicators of this disease encompass:

• discomfort in the stomach or back
• weight loss
• yellowing of skin and eyes
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• nausea

At 51 years old, D’Angelo’s death is an exception, as pancreatic cancer is typically found in adults in the 65 to 75 age bracket. However, numerous malignancies, such as pancreatic cancer, have become more common in younger people.

“This disease identified prior to fifty is deemed uncommon, yet concerningly, clinicians are noticing a growing number of younger patients suffering from this condition,” said a specialist.

Genetic Background Impacts Disease Probability

Without effective screening tools for pancreatic cancer, experts stressed the significance of understanding your relatives’ health background. Some contributing elements, such as tobacco use and excess weight also have an influence in the development of this disease.

African Americans have the greatest occurrence of this malignancy in the U.S. and are more prone to be diagnosed with untreatable disease.

“The first step toward reducing one’s chance of pancreatic cancer is understanding personal risk factors. People should examine their genetic background, genetic background, and medical conditions, such as diabetes, chronic pancreatitis, or obesity that may raise their vulnerability,” said a medical professional.

Inherited genetic risk factors are linked to as much as ten percent of all this malignancy cases. If someone in your family has had pancreatic cancer, you may want to think about genetic testing.

“For individuals with a family history of this condition or those carrying high risk DNA changes, checking may involve sophisticated scans such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to detect early changes in the pancreas,” he explained.

For those wishing to reduce their risk, habit adjustments may have an effect. The best action you can take to lower your risk of pancreatic cancer is to quit smoking, and if you don’t smoke, avoid exposure altogether.

Heavy alcohol consumption is associated with pancreatitis, a risk factor for pancreatic cancer, so reducing or avoiding alcohol may help reduce your risk.

Managing your body mass or losing weight may also help decrease your susceptibility. People with obesity are 20% more likely to get this disease. This malignancy also is more frequent in those with diabetes, and reducing weight can also lower the risk of type 2 diabetes.

Despite this disease’s grim outlook, there is still hope.

“We are doing better with treatments and more recent mixed drug treatments. There are developing precision medicines that already are making an impact,” remarked a specialist.

For numerous people, however, awareness about this rare but {dev